THBS1 and metastatic neoplasm: The most notable difference was seen when comparing metastatic vs non-metastatic tumors, where the samples from patients with metastatic tumors had significantly higher expression of THBS1 compared to those from patients with non-metastatic tumors (p = 0.0192, 4.53-fold change) (Figure 4A).